NCT01466972 2020-07-08
Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
University of California, San Francisco
Phase 2 Completed
University of California, San Francisco
Stanford University
Grupo Español de Investigación en Cáncer de Ovario
GlaxoSmithKline
GlaxoSmithKline